Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2016/3151986 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559858257231872 |
|---|---|
| author | Xiao-Wen Chen Xiao-Yan Du Yu-Xian Wang Jian-Cheng Wang Wen-Ting Liu Wen-Jing Chen Hong-Yu Li Fen-Fen Peng Zhao-Zhong Xu Hong-Xin Niu Hai-Bo Long |
| author_facet | Xiao-Wen Chen Xiao-Yan Du Yu-Xian Wang Jian-Cheng Wang Wen-Ting Liu Wen-Jing Chen Hong-Yu Li Fen-Fen Peng Zhao-Zhong Xu Hong-Xin Niu Hai-Bo Long |
| author_sort | Xiao-Wen Chen |
| collection | DOAJ |
| format | Article |
| id | doaj-art-c013ce5863824832806670836a79bddd |
| institution | Kabale University |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-c013ce5863824832806670836a79bddd2025-02-03T01:29:03ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/31519863151986Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”Xiao-Wen Chen0Xiao-Yan Du1Yu-Xian Wang2Jian-Cheng Wang3Wen-Ting Liu4Wen-Jing Chen5Hong-Yu Li6Fen-Fen Peng7Zhao-Zhong Xu8Hong-Xin Niu9Hai-Bo Long10Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Gerontology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Emergency, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, ChinaDepartment of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, Chinahttp://dx.doi.org/10.1155/2016/3151986 |
| spellingShingle | Xiao-Wen Chen Xiao-Yan Du Yu-Xian Wang Jian-Cheng Wang Wen-Ting Liu Wen-Jing Chen Hong-Yu Li Fen-Fen Peng Zhao-Zhong Xu Hong-Xin Niu Hai-Bo Long Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice” Mediators of Inflammation |
| title | Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice” |
| title_full | Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice” |
| title_fullStr | Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice” |
| title_full_unstemmed | Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice” |
| title_short | Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice” |
| title_sort | corrigendum to irbesartan ameliorates diabetic nephropathy by suppressing the rankl rank nf κb pathway in type 2 diabetic db db mice |
| url | http://dx.doi.org/10.1155/2016/3151986 |
| work_keys_str_mv | AT xiaowenchen corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT xiaoyandu corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT yuxianwang corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT jianchengwang corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT wentingliu corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT wenjingchen corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT hongyuli corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT fenfenpeng corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT zhaozhongxu corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT hongxinniu corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice AT haibolong corrigendumtoirbesartanamelioratesdiabeticnephropathybysuppressingtheranklranknfkbpathwayintype2diabeticdbdbmice |